BACKGROUND: Human myocardial metabolism has been incompletely characterized in the setting of surgical cardioplegic arrest and ischemia/reperfusion. Furthermore, the effect of preexisting ventricular state on ischemia-induced metabolic derangements has not been established. METHODS AND RESULTS: We applied a mass spectrometry-based platform to profile 63 intermediary metabolites in serial paired peripheral arterial and coronary sinus blood effluents obtained from 37 patients undergoing cardiac surgery, stratified by presence of coronary artery disease and left ventricular dysfunction. The myocardium was a net user of a number of fuel substrates before ischemia, with significant differences between patients with and without coronary artery disease. After reperfusion, significantly lower extraction ratios of most substrates were found, as well as significant release of 2 specific acylcarnitine species, acetylcarnitine and 3-hydroxybutyryl-carnitine. These changes were especially evident in patients with impaired ventricular function, who exhibited profound limitations in extraction of all forms of metabolic fuels. Principal component analysis highlighted several metabolic groupings as potentially important in the postoperative clinical course. CONCLUSIONS: The preexisting ventricular state is associated with significant differences in myocardial fuel uptake at baseline and after ischemia/reperfusion. The dysfunctional ventricle is characterized by global suppression of metabolic fuel uptake and limited myocardial metabolic reserve and flexibility after global ischemia/reperfusion stress in the setting of cardiac surgery. Altered metabolic profiles after ischemia/reperfusion are associated with postoperative hemodynamic course and suggest a role for perioperative metabolic monitoring and targeted optimization in cardiac surgical patients.
BACKGROUND:Human myocardial metabolism has been incompletely characterized in the setting of surgical cardioplegic arrest and ischemia/reperfusion. Furthermore, the effect of preexisting ventricular state on ischemia-induced metabolic derangements has not been established. METHODS AND RESULTS: We applied a mass spectrometry-based platform to profile 63 intermediary metabolites in serial paired peripheral arterial and coronary sinus blood effluents obtained from 37 patients undergoing cardiac surgery, stratified by presence of coronary artery disease and left ventricular dysfunction. The myocardium was a net user of a number of fuel substrates before ischemia, with significant differences between patients with and without coronary artery disease. After reperfusion, significantly lower extraction ratios of most substrates were found, as well as significant release of 2 specific acylcarnitine species, acetylcarnitine and 3-hydroxybutyryl-carnitine. These changes were especially evident in patients with impaired ventricular function, who exhibited profound limitations in extraction of all forms of metabolic fuels. Principal component analysis highlighted several metabolic groupings as potentially important in the postoperative clinical course. CONCLUSIONS: The preexisting ventricular state is associated with significant differences in myocardial fuel uptake at baseline and after ischemia/reperfusion. The dysfunctional ventricle is characterized by global suppression of metabolic fuel uptake and limited myocardial metabolic reserve and flexibility after global ischemia/reperfusion stress in the setting of cardiac surgery. Altered metabolic profiles after ischemia/reperfusion are associated with postoperative hemodynamic course and suggest a role for perioperative metabolic monitoring and targeted optimization in cardiac surgical patients.
Authors: Pedro N Chavez; William C Stanley; Tracy A McElfresh; Hazel Huang; Joseph P Sterk; Margaret P Chandler Journal: Am J Physiol Heart Circ Physiol Date: 2003-01-09 Impact factor: 4.733
Authors: T Ide; H Tsutsui; S Hayashidani; D Kang; N Suematsu; K Nakamura; H Utsumi; N Hamasaki; A Takeshita Journal: Circ Res Date: 2001-03-16 Impact factor: 17.367
Authors: M A Martín; M A Gómez; F Guillén; B Börnstein; Y Campos; J C Rubio; C S de la Calzada; J Arenas Journal: Biochim Biophys Acta Date: 2000-11-15
Authors: F Alamanni; A Parolari; A Repossini; E Doria; F Bortone; J Campolo; M Pepi; E Sisillo; M Naliato; R Bigi; P Biglioli; O Parodi Journal: Heart Date: 2004-11 Impact factor: 5.994
Authors: Biao Lei; Vincenzo Lionetti; Martin E Young; Margaret P Chandler; Chiara d'Agostino; Elaine Kang; Martin Altarejos; Ken Matsuo; Thomas H Hintze; William C Stanley; Fabio A Recchia Journal: J Mol Cell Cardiol Date: 2004-04 Impact factor: 5.000
Authors: Víctor G Dávila-Román; Giridhar Vedala; Pilar Herrero; Lisa de las Fuentes; Joseph G Rogers; Daniel P Kelly; Robert J Gropler Journal: J Am Coll Cardiol Date: 2002-07-17 Impact factor: 24.094
Authors: Jie An; Deborah M Muoio; Masakazu Shiota; Yuka Fujimoto; Gary W Cline; Gerald I Shulman; Timothy R Koves; Robert Stevens; David Millington; Christopher B Newgard Journal: Nat Med Date: 2004-02-08 Impact factor: 53.440
Authors: Aslan T Turer; Craig R Malloy; Christopher B Newgard; Mihai V Podgoreanu Journal: Curr Opin Clin Nutr Metab Care Date: 2010-07 Impact factor: 4.294
Authors: Haipeng Sun; Kristine C Olson; Chen Gao; Domenick A Prosdocimo; Meiyi Zhou; Zhihua Wang; Darwin Jeyaraj; Ji-Youn Youn; Shuxun Ren; Yunxia Liu; Christoph D Rau; Svati Shah; Olga Ilkayeva; Wen-Jun Gui; Noelle S William; R Max Wynn; Christopher B Newgard; Hua Cai; Xinshu Xiao; David T Chuang; Paul Christian Schulze; Christopher Lynch; Mukesh K Jain; Yibin Wang Journal: Circulation Date: 2016-04-08 Impact factor: 29.690
Authors: David P Kao; Brian D Lowes; Edward M Gilbert; Wayne Minobe; L Elaine Epperson; Leslie K Meyer; Debra A Ferguson; Ann Kirkpatrick Volkman; Ronald Zolty; C Douglas Borg; Robert A Quaife; Michael R Bristow Journal: Circ Cardiovasc Genet Date: 2015-01-30
Authors: Emirhan Nemutlu; Song Zhang; Yi-Zhou Xu; Andre Terzic; Li Zhong; Petras D Dzeja; Yong-Mei Cha Journal: J Card Fail Date: 2015-04-22 Impact factor: 5.712
Authors: Quintin J Quinones; Zhiquan Zhang; Qing Ma; Michael P Smith; Erik Soderblom; M Arthur Moseley; James Bain; Christopher B Newgard; Michael J Muehlbauer; Matthew Hirschey; Kelly L Drew; Brian M Barnes; Mihai V Podgoreanu Journal: Anesthesiology Date: 2016-06 Impact factor: 7.892
Authors: James R Bain; Robert D Stevens; Brett R Wenner; Olga Ilkayeva; Deborah M Muoio; Christopher B Newgard Journal: Diabetes Date: 2009-11 Impact factor: 9.461